Beijing Scitop Bio-tech Co., Ltd. (SHE:300858)
15.77
-0.42 (-2.59%)
Jun 2, 2026, 3:04 PM CST
Beijing Scitop Bio-tech Revenue
Beijing Scitop Bio-tech had revenue of 85.00M CNY in the quarter ending March 31, 2026, with 9.51% growth. This brings the company's revenue in the last twelve months to 373.31M, up 16.16% year-over-year. In the year 2025, Beijing Scitop Bio-tech had annual revenue of 365.92M with 20.85% growth.
Revenue (ttm)
373.31M
Revenue Growth
+16.16%
P/S Ratio
11.13
Revenue / Employee
903.89K
Employees
413
Market Cap
4.16B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 365.92M | 63.13M | 20.85% |
| Dec 31, 2024 | 302.79M | 3.55M | 1.19% |
| Dec 31, 2023 | 299.24M | -69.92M | -18.94% |
| Jan 1, 2023 | 369.17M | 4.55M | 1.25% |
| Dec 31, 2021 | 364.62M | 25.46M | 7.51% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Wuhan Hvsen Biotechnology | 1.74B |
| Kexing Biopharm | 1.46B |
| ChemPartner PharmaTech | 1.13B |
| Boji Medical Technology | 949.94M |
| Beijing Bohui Innovation Biotechnology Group | 812.78M |
| Lifecome Biochemistry | 502.95M |
| Assure Tech (Hangzhou) | 409.48M |
| Jiangsu Bioperfectus Technologies | 326.02M |
Beijing Scitop Bio-tech News
- 5 weeks ago - Beijing Scitop Bio-tech Annual report: Q4 2025 - Filings
- 5 weeks ago - Beijing Scitop Bio-tech Quarterly report: Q1 2026 - Filings
- 8 months ago - Beijing Scitop Bio-tech Quarterly report: Q3 2025 - Filings
- 10 months ago - Beijing Scitop Bio-tech Quarterly report: Q2 2025 - Filings